Literature DB >> 2886343

Studies on the central effects of the H1-antagonist, loratadine.

C M Bradley, A N Nicholson.   

Abstract

Effects of loratadine (10, 20 and 40 mg) on visuo-motor coordination, dynamic visual acuity, short-term memory, digit symbol substitution, and on subjective assessments of mood were tested before, and 0.5, 1.5, 3.5 and 5.5 h after ingestion by 6 healthy female adults. There were no effects of 10 or 20 mg loratadine. With 40 mg loratadine the number of substitutions on the digit symbol test was reduced 5.5 h after ingestion, and on dynamic visual acuity response time was increased at 3.5 h and the number of responses missed was increased at 5.5 h. Triprolidine (10 mg) which was used as active control impaired performance on all the tasks and impaired performance was observed at all times after ingestion. Loratadine is a promising antihistamine for individuals involved in skilled activity. The anticipated single daily dose of 10 mg is unlikely to impair performance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886343     DOI: 10.1007/bf00543979

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Human performance after a barbiturate (heptabarbitone).

Authors:  R G Borland; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

2.  Performance studies with antihistamines.

Authors:  C H Clarke; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

3.  Antihistaminic activity and central effects of terfenadine. A review of European studies.

Authors:  A N Nicholson
Journal:  Arzneimittelforschung       Date:  1982

4.  Central effects of H1 and H2 antihistamines.

Authors:  A N Nicholson
Journal:  Aviat Space Environ Med       Date:  1985-04

5.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

6.  Hypnotic activity and effects on performance of lormetazepam and camazepam--analogues of temazepam.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

7.  Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light.

Authors:  A N Nicholson; P A Smith; M B Spencer
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

8.  The H1-antagonist mequitazine: studies on performance and visual function.

Authors:  A N Nicholson; B M Stone
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

  9 in total
  15 in total

Review 1.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene.

Authors:  A N Nicholson; P A Pascoe; C Turner; C R Ganellin; P M Greengrass; A F Casy; A D Mercer
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 3.  Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

Review 4.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

Review 5.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.

Authors:  Consuelo García-Gea; Maria Rosa Ballester; Juan Martínez; Rosa Maria Antonijoan; Esther Donado; Iñaki Izquierdo; Manuel-José Barbanoj
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

7.  Effects of roxithromycin on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.

Authors:  Cheng Li; Cheul-Seol Kim; Jeong-Yeol Yang; Yeong-Jin Park; Jun-Shik Choi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

Review 8.  Effects of antihistamine medications on exercise performance. Implications for sportspeople.

Authors:  L C Montgomery; P A Deuster
Journal:  Sports Med       Date:  1993-03       Impact factor: 11.136

9.  Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.

Authors:  A Patat; M C Perault; B Vandel; N Ulliac; I Zieleniuk; P Rosenzweig
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.

Authors:  K A Brookhuis; G De Vries; D De Waard
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.